<DOC>
	<DOCNO>NCT02454439</DOCNO>
	<brief_summary>The aim NICD-CRT study ass whether CRT may clinically beneficial HF patient NICD reduce ejection fraction 12-month HF status . In effect , effectiveness cardiac resynchronization therapy heart failure ( HF ) reduce ejection fraction patient non specific intraventricular conduction delay ( NICD ) never confirm even recommend . At moment , dedicate study already perform assess benefit CRT patient NICD . Results CRT therapy contradictory patient group obtain subgroup analysis . Some n't show clinical benefit others show benefit term end-diastolic and/or end-systolic leave ventricular volume ( decrease size volume leave ventricule ) . The AHA/ACCF guideline , publish 2005 updated 2009 , consider QRS duration ( ≥120 m ) indication CRT implantation , without consideration type conduction disorder ( i.e . LBBB vs. non-LBBB ) , current updated 2012 ACCF/AHA/HRS guideline , consider QRS morphology ( i.e . LBBB ) first step CRT candidate selection addition QRS duration ( &gt; 150 m ) . Indications resynchronization restrict since indication CRT non-LBBB patient ( e.g . NICD ) class IIa ( &gt; 150 m , NYHA III ambulatory IV ; level evidence A ) . The modification apply 2011 2013 European guideline . None know patient NICD QRS &gt; 130 m .</brief_summary>
	<brief_title>Assessment Cardiac Resynchronization Therapy Patients With Wide QRS Non-specific Intraventricular Conduction Delay : Randomized Trial</brief_title>
	<detailed_description>This pilot , prospective , control , two-parallel arm , randomize , double-blind design multicentric clinical trial compare CRT-D CRT-P ON group vs. CRT-D CRT-P OFF group HF reduce ejection fraction patient NICD . Patients include twelve French center ( Clermont-Ferrand University Hospital , Côte Basque Hospital , Bordeaux University Hospital , Saint-Augustin Clinic , Limoges University Hospital , Grenoble University Hospital , Nantes University Hospital , Nantes New Clinic , Rennes University Hospital , Saint-Etienne University Hospital , Tours University Hospital , Toulouse University Hospital ) . 1 . At baseline preimplantation evaluation perform : clinical examination , ECG , six minute walk test , biology analysis , quality life assessment , echocardiography , peak oxygen consumption . 2 . At 6 month , evaluation efficacy secondary assessment criterion : - Quality life : Minnesota Living With Heart Failure Questionnary : MLWHFQ ) : improvement least 20 point - Functionnal capacity : NYHA classification reduction ≥ 1 class , 6-minute walk test improvement least 10 % distance , Peak oxygen consumption increase 1.0 ml/kg/minNYHA response CRT primary endpoint . It composite primary endpoint , include modification : Quality Life Score ( MINNESOTA scale ) , NYHA functional status , 6-minute walk test volume leave ventricle . - Percentage hospitalization HF , cardiovascular reason cause Decrease &gt; 15 % end-diastolic and/or end-systolic volume leave ventricle . 3 . At 12 month , comparison proportion improve , unchanged worsend patient ( Packer Score ) group primary endpoint new evaluation CRT efficacy ( 6 month )</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Patients 18 year ' old NYHA class II IV ambulatory QRS duration &gt; 130 m Patients sinus rhythm LVEF &lt; 35 % QRS morphology : NICD accord AHA/ACCF/HRS Recommendations ( nonLBBB nonRBBB ) : Not broad notch slur R wave lead I , aVL , V5 V6 ; Presence Q wave lead I , V5 , V6 ; No rsr ' , rsR ' rSR ' pattern lead V1 V2 . Life expectancy expect exceed one year good functional status Optimal pharmacological therapy heart failure accord clinician</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Heart Failure reduce ejection fraction ( &lt; 35 % )</keyword>
	<keyword>Cardiac Resynchronisation Therapy</keyword>
	<keyword>Non specific intraventricular conduction</keyword>
	<keyword>Efficacy</keyword>
	<keyword>Life expectancy expect exceed one year good functional status</keyword>
	<keyword>QRS morphology : NICD accord AHA/ACCF/HRS Recommendations ( non-LBBB non-RBBB ) :</keyword>
	<keyword>QRS duration &gt; 130 m</keyword>
</DOC>